LENZ logo

LENZ

LENZ Therapeutics, Inc.NASDAQHealthcare
$9.67+3.42%ClosedMarket Cap: $303.2M

As of 2026-04-06

Insider Statistics (Q4 2025)

Purchases

4

Sales

3

Buy/Sell Ratio

1.33

Total Bought

$3.00

Total Sold

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon Mar 30Chevallard Daniel R.officer: Chief Financial OfficerBuy7,500$8.5712,886
Mon Mar 30Schimmelpennink Evert B.director, officer: President, CEO and SecretaryBuy28,089$8.9577,289
Mon Mar 30George Jeffrey P.directorBuy5,592$8.925,592
Tue Jan 06Odrich Marcofficer: Chief Medical OfficerSell14,000$0.0014,000
Tue Jan 06Chevallard Daniel R.officer: Chief Financial OfficerSell84,200$16.0084,200
Tue Jan 06Chevallard Daniel R.officer: Chief Financial OfficerSell14,000$0.0014,000
Tue Jan 06Olsson Shawnofficer: Chief Commercial OfficerSell84,200$16.0084,200
Tue Jan 06Schimmelpennink Evert B.director, officer: President, CEO and SecretarySell358,100$16.00358,100
Tue Jan 06Olsson Shawnofficer: Chief Commercial OfficerSell14,000$0.0014,000
Tue Jan 06Odrich Marcofficer: Chief Medical OfficerSell84,200$16.0084,200
Wed Nov 19Olsson Shawnofficer: Chief Commercial OfficerSell4,212$25.7410,521
Wed Nov 19Olsson Shawnofficer: Chief Commercial OfficerSell10,000$2.0853,241